Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doris Riether

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Expert Opinion on Therapeutic Patents|April 28, 2012
Selective cannabinoid receptor 2 modulators: a patent review 2009--presentDoris Riether
Bioorganic & Medicinal Chemistry Letters|January 12, 2023
Synthesis of 2'-modified N6-methyladenosine phosphoramidites and their incorporation into siRNAAnna M Rydzik, Doris Riether, Dirk Gottschling
Organic Letters|August 23, 2021
Access to 1'-Amino Carbocyclic Phosphoramidite to Enable Postsynthetic Functionalization of OligonucleotidesAnna M Rydzik, Regina Balk, Martin Koegler, et al.
Chembiochem : a European Journal of Chemical Biology|September 16, 2020
Epigenetic Modification 6-Methyladenosine Can Impact the Potency and Specificity of siRNAAnna M Rydzik, Dirk Gottschling, Eric Simon, et al.
Journal of the American Chemical Society|July 3, 2003
Reactivity of functional groups on the protein surface: development of epoxide probes for protein labelingGong Chen, Alexander Heim, Doris Riether, et al.
Journal of Chemical Information and Modeling|November 24, 2021
Identification of Highly Selective Orexin 1 Receptor Antagonists Driven by Structure-Based DesignUta Lessel, Marco Ferrara, Niklas Heine, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2015
Selective CB2 receptor agonists. Part 1: the identification of novel ligands through computer-aided drug design (CADD) approachesEugene R Hickey, Renee Zindell, Pier F Cirillo, et al.
Bioorganic & Medicinal Chemistry Letters|February 27, 2009
Morpholine containing CB2 selective agonistsRenée Zindell, Doris Riether, Todd Bosanac, et al.
Bioorganic & Medicinal Chemistry Letters|January 11, 2015
Selective CB2 receptor agonists. Part 3: the optimization of a piperidine-based series that demonstrated efficacy in an in vivo neuropathic pain modelAlessandra Bartolozzi, Pier Francesco Cirillo, Angela K Berry, et al.
Bioorganic & Medicinal Chemistry Letters|September 21, 2017
Discovery and optimization of oxadiazole-based FLAP inhibitorsAlessandra Bartolozzi, Asitha Abeywardane, Todd Bosanac, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Expert Opinion on Therapeutic Patents|April 28, 2012
Selective cannabinoid receptor 2 modulators: a patent review 2009--presentDoris Riether
Bioorganic & Medicinal Chemistry Letters|January 12, 2023
Synthesis of 2'-modified N6-methyladenosine phosphoramidites and their incorporation into siRNAAnna M Rydzik, Doris Riether, Dirk Gottschling
Organic Letters|August 23, 2021
Access to 1'-Amino Carbocyclic Phosphoramidite to Enable Postsynthetic Functionalization of OligonucleotidesAnna M Rydzik, Regina Balk, Martin Koegler, et al.
Chembiochem : a European Journal of Chemical Biology|September 16, 2020
Epigenetic Modification 6-Methyladenosine Can Impact the Potency and Specificity of siRNAAnna M Rydzik, Dirk Gottschling, Eric Simon, et al.
Journal of the American Chemical Society|July 3, 2003
Reactivity of functional groups on the protein surface: development of epoxide probes for protein labelingGong Chen, Alexander Heim, Doris Riether, et al.
Journal of Chemical Information and Modeling|November 24, 2021
Identification of Highly Selective Orexin 1 Receptor Antagonists Driven by Structure-Based DesignUta Lessel, Marco Ferrara, Niklas Heine, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2015
Selective CB2 receptor agonists. Part 1: the identification of novel ligands through computer-aided drug design (CADD) approachesEugene R Hickey, Renee Zindell, Pier F Cirillo, et al.
Bioorganic & Medicinal Chemistry Letters|February 27, 2009
Morpholine containing CB2 selective agonistsRenée Zindell, Doris Riether, Todd Bosanac, et al.
Bioorganic & Medicinal Chemistry Letters|January 11, 2015
Selective CB2 receptor agonists. Part 3: the optimization of a piperidine-based series that demonstrated efficacy in an in vivo neuropathic pain modelAlessandra Bartolozzi, Pier Francesco Cirillo, Angela K Berry, et al.
Bioorganic & Medicinal Chemistry Letters|September 21, 2017
Discovery and optimization of oxadiazole-based FLAP inhibitorsAlessandra Bartolozzi, Asitha Abeywardane, Todd Bosanac, et al.
Pageof 3